Gut microbiota-derived formate exacerbates pulmonary metastasis in cancer
Theranostics · 2025
DOI: 10.7150/thno.108873 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Ray Putra Prajnamitra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lung Neoplasms, Formates, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
The gut microbiota and its metabolites significantly influence cancer development and metastasis. Among these, formate, the simplest short-chain fatty acid (SCFA), remains underexplored in the context of metastasis. This study investigates the role of microbiota-derived formate in exacerbating pulmonary metastasis in melanoma and pancreatic ductal adenocarcinoma (PDAC), aiming to elucidate its mechanistic contributions to cancer progression.
Methods
Using antibiotics-induced dysbiosis in mice, we quantified plasma formate levels via nuclear magnetic resonance (NMR) metabolomics and identified gut bacterial contributors through 16S rRNA sequencing. Formate's effects on melanoma and PDAC lung metastases were evaluated through in vivo supplementation experiments. Cellular assays, metabolomics, and gene expression analyses further elucidated its mechanistic impact.
Results
Dysbiosis significantly increased circulating formate levels, with Enterobacterales identified as key contributors. Formate supplementation enhanced melanoma and PDAC lung metastases by promoting cancer cell proliferation, migration, and nucleotide synthesis. Mechanistic studies revealed that formate upregulated one-carbon metabolism, critical for tumor aggressiveness, and increased the production of metabolites like glutathione, facilitating oxidative stress resistance.
Conclusion
Microbiota-derived formate plays a critical role in enhancing pulmonary metastasis by modulating cancer cell metabolism. These findings highlight the therapeutic potential of targeting formate production or its associated metabolic pathways to mitigate cancer spread. Additionally, microbiome modulation emerges as a promising complementary approach to improving cancer treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
- Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan.
- Institute of Medical Genomics and Proteomics and Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei 100, Taiwan.
Zitieren
APA
Prajnamitra, R. P., Beh, C. Y., Tang, W. H., Ruan, S. C., Cheng, Y. Y., Kuo, P. T., Tien, Y. W., & Hsieh, P. C. (2025). Gut microbiota-derived formate exacerbates pulmonary metastasis in cancer. Theranostics. https://doi.org/10.7150/thno.108873
Vancouver
Prajnamitra RP, Beh CY, Tang WH, Ruan SC, Cheng YY, Kuo PT, et al. Gut microbiota-derived formate exacerbates pulmonary metastasis in cancer. Theranostics. 2025. doi:10.7150/thno.108873
BibTeX
@article{Prajnamitra2025,
author = {Prajnamitra, Ray Putra and Beh, Chaw Yee and Tang, Wen-Hung and Ruan, Shu-Chian and Cheng, Yuan-Yuan and Kuo, Pei-Teng and Tien, Yu-Wen and Hsieh, Patrick Ching-Ho},
title = {Gut microbiota-derived formate exacerbates pulmonary metastasis in cancer},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.108873}
}
EUVIMED